A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26188941 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kyung-Jun Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of New Frontier Research Team, Hallym University, Chuncheon 24252, Republic of Korea. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, T-Lymphocytes, Thromboplastin. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hallym University Medical Center, Hallym University Research Fund.
Abstract (Originalsprache)
Tissue factor (TF), also known as CD142, is a 47 kDa transmembrane glycoprotein belonging to the class II cytokine receptors superfamily. High expression of TF has been reported to be correlated with poor prognosis in various cancers. In this study, we aimed to clarify the cytotoxicity of bi-specific T-cell engagers (BiTE) targeting TF on cervical cancer cell lines. We designed and characterized the novel humanized BiTE targeting TF using an anti-human CD3 single-chain variable fragment (scFv) linked to human TF scFv. TF-Bite replication and potency were assessed in cervical cancer cell lines. The expression of the TF-BiTE and the activation and proliferation of T cells induced along with the T-cell-mediated cytotoxicity were evaluated by flow cytometry in vitro. TF expression was confirmed in SiHa, ME-180, and HeLa cell lines. The TF-BiTE showed potent TF-specific cytotoxicity and induced T-cell activation, proliferation, degranulation, and cytokine release. These effects were not observed in TF-negative control cells. Our findings support TF-BiTE as a promising therapeutic candidate for cervical cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of New Frontier Research Team, Hallym University, Chuncheon 24252, Republic of Korea.
- Department of Pathology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republic of Korea.
- Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
- Department of Biology, Johns Hopkins University, 3400 N. Charles St., Baltimore, MD 21218, USA.
- Department of Obstetrics and Gynecology, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republic of Korea.
- Division of Hemato-Oncology, Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republic of Korea.
ORCID-Profile: Gilhyang Kim, Hye-Yon Cho, Sung Taek Park
Förderung
- Hallym University Medical Center
- Hallym University Research Fund
Zitieren
APA
Lee, K. J., Kim, G., Seo, B., Jeong, S. Y., Kim, H. S., Cho, H. Y., & Park, S. T. (2025). A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188941
Vancouver
Lee KJ, Kim G, Seo B, Jeong SY, Kim HS, Cho HY, et al. A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188941
BibTeX
@article{Lee2025,
author = {Lee, Kyung-Jun and Kim, Gilhyang and Seo, Booseong and Jeong, Soo Young and Kim, Hyeong Su and Cho, Hye-Yon and Park, Sung Taek},
title = {A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26188941}
}
EUVIMED